Molecular Alterations and Estimated Indoor Radon in NSCLC Patients from the French National Cancer Institute Registry: Radon France Study [OA09.06]

Mezquita, L.; Barlesi, F.; Auclin, E.; Planchard, D.; Botticella, A.; Gazzah, A.; Lavaud, P.; Aboubakar Nana, Frank; Lepéchoux, C.; Besse, B.

doi:10.1016/j.jtho.2018.08.285

Molecular Alterations and Estimated Indoor Radon in NSCLC Patients from the French National Cancer Institute Registry: Radon France Study [OA09.06]

Mezquita, L.

;

Barlesi, F.

;

Auclin, E.

;

Planchard, D.

;

Besse, B.

;et.al.

(2018) IASLC 19th World Conference on Lung Cancer — Location: (Canada) Toronto (23.September.2018)

Files

2018_Mezquita_J_Thorac_Oncol_OA0906.pdf

Open Access
Adobe PDF
249.41 KB

Download

Details

Authors

Mezquita, L.
Author
Barlesi, F.
Author
Auclin, E.
Author
Planchard, D.
Author
Aboubakar Nana, FrankUCLouvain
Author
Besse, B.
Author

Abstract

BACKGROUND : Radon is a radioactive gas, considered the leading cause of lung cancer in non-smokers. We assessed the correlation between the radon exposure areas in France and the molecular alterations nationally registered in non-small cell lung cancer (NSCLC) patients. [...]

Affiliations

Citations

APA
Chicago
FWB

Mezquita, L., Barlesi, F., Auclin, E., Planchard, D., Botticella, A., Gazzah, A., Lavaud, P., Aboubakar Nana, F., Lepéchoux, C., & Besse, B. (2018). Molecular Alterations and Estimated Indoor Radon in NSCLC Patients from the French National Cancer Institute Registry: Radon France Study [OA09.06]. Journal of Thoracic Oncology, 13(10), S342. https://doi.org/10.1016/j.jtho.2018.08.285 (Original work published 2018)